|
CGGBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67770000003564E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.84239999998248E-06 |
| Normal-vs-Stage2 |
2.442100E-02 |
| Normal-vs-Stage3 |
1.396220E-04 |
| Normal-vs-Stage4 |
3.73350000004713E-06 |
| Stage1-vs-Stage2 |
7.140800E-01 |
| Stage1-vs-Stage3 |
2.399600E-01 |
| Stage1-vs-Stage4 |
1.707010E-01 |
| Stage2-vs-Stage3 |
2.525800E-01 |
| Stage2-vs-Stage4 |
1.236840E-01 |
| Stage3-vs-Stage4 |
5.746600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.06849999998082E-06 |
| Normal-vs-AfricanAmerican |
1.154970E-04 |
| Normal-vs-Asian |
1.619750E-03 |
| Caucasian-vs-AfricanAmerican |
9.822000E-01 |
| Caucasian-vs-Asian |
5.467400E-01 |
| AfricanAmerican-vs-Asian |
5.012600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5901999994572E-07 |
| Normal-vs-Female |
2.219600E-02 |
| Male-vs-Female |
2.329800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.419700E-04 |
| Normal-vs-Extreme_Weight |
1.15950000001419E-06 |
| Normal-vs-Obese |
1.426440E-04 |
| Normal-vs-Extreme_Obese |
5.176300E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.675200E-01 |
| Normal_Weight-vs-Obese |
6.650800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.027600E-01 |
| Extreme_Weight-vs-Obese |
3.275200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.878800E-01 |
| Obese-vs-Extreme_Obese |
4.013800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.462400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.361800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.29879999977156E-07 |
| Normal-vs-Age(81-100Yrs) |
6.0473999999977E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.018800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.455700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.530300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.020000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.334030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.408800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.225400E-04 |
| Normal-VS-Type2 PRCC |
1.43449996325984E-09 |
| Normal-VS-KIRP CIMP |
1.330240E-02 |
| Normal-VS-Unclassified PRCC |
2.496000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.172800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.530200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.843600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.363240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.637600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.194800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.10140005186111E-09 |
| Normal-vs-N1 |
1.274140E-02 |
| Normal-vs-N2 |
6.179300E-04 |
| N0-vs-N1 |
1.229180E-01 |
| N0-vs-N2 |
4.501200E-01 |
| N1-vs-N2 |
2.340600E-01 |
|
|
